Clinical Trials
33 trialsIn This Study, a Retrospective Analysis Was Conducted to Explore the Risk Factors for Patients Undergoing Pancreaticoduodenal Surgery (PD) to Achieve TO, and a Nomogram Prediction Model Was Further Established to Promote the Standardization and Standardization of PD Surgical Quality Evaluation.
Changzhou No.2 People's Hospital
Prognostic Factors for Survival in Patients With Cholangiocarcinoma
Rigshospitalet, Denmark
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
BESTDRAIN
Radboud University Medical Center
CCGLC-009
Tongji Hospital
Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions
Soonchunhyang University Hospital
Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy
Zhejiang Cancer Hospital
Hepatobiliary Tumors Tissue Samples Acquisition
Peking Union Medical College Hospital
ctDNA Detection of MRD in Predicting Postoperative Recurrence in Biliary Tract Cancers:A Multicenter Prospective Trial
The First Affiliated Hospital with Nanjing Medical University
Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma
Power Life Sciences Inc.
Study on the Accuracy of Proteomics in Evaluating Lymph Node Metastasis Status in Cholangiocarcinoma Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
FOCUS
Academisch Ziekenhuis Maastricht
Study on Consistency Evaluation for Drug Sensitivity of Patient-Derived Organoid Model From Cholangiocarcinoma Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer
Seoul National University Hospital
A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection
Fudan University
Observational Study on Patients With Hepatobiliary Tumors
First Affiliated Hospital of Wenzhou Medical University
Establishment of Scoring Model for Early and Differential Diagnosis of Intrahepatic Cholangiocarcinoma
Qilu Hospital of Shandong University
PIONEER
SpeciCare
the Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients
Central Hospital, Nancy, France
Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study
Beijing Tsinghua Chang Gung Hospital
VLE-IOV
Innovative Digestive Health Education and Research Inc
CHOLANGIO
International Group of Endovascular Oncology
Precise Treatment System of Biliary Malignancies Based on Special Disease Database
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
ncRNAs in Exosomes of Cholangiocarcinoma
The Second Hospital of Nanjing Medical University
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
Weill Medical College of Cornell University
RFA-Registry
Weill Medical College of Cornell University
EUSERCPReg
Weill Medical College of Cornell University
Optimization of Health Expenditure in Liver Surgery
Centre Hospitalier Universitaire, Amiens
Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors
Fondazione del Piemonte per l'Oncologia
In Vitro Models of Liver and Pancreatic Cancer
Cambridge University Hospitals NHS Foundation Trust
EtherBil
University of Bologna
VEGF ECC
First Affiliated Hospital, Sun Yat-Sen University
icc
First Affiliated Hospital, Sun Yat-Sen University